Skip to Content

Aptose Biosciences Inc APTO

Morningstar Rating
$1.86 +0.08 (4.49%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

APTO is trading at a 59% discount.
Price
$1.85
Fair Value
$7.54
Uncertainty
Extreme
1-Star Price
$92.92
5-Star Price
$2.32
Economic Moat
Qvvtp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if APTO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.78
Day Range
$1.781.86
52-Week Range
$1.7710.20
Bid/Ask
$1.80 / $1.86
Market Cap
$29.21 Mil
Volume/Avg
61,737 / 75,942

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
36

Valuation

Metric
APTO
Price/Earnings (Normalized)
Price/Book Value
1.89
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
APTO
Quick Ratio
1.43
Current Ratio
1.59
Interest Coverage
Quick Ratio
APTO

Profitability

Metric
APTO
Return on Assets (Normalized)
−115.82%
Return on Equity (Normalized)
−170.83%
Return on Invested Capital (Normalized)
−169.50%
Return on Assets
APTO
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRShyg$550.2 Bil
VRTX
Vertex Pharmaceuticals IncGqywwl$111.1 Bil
REGN
Regeneron Pharmaceuticals IncZcytyj$107.7 Bil
MRNA
Moderna IncRmwbp$36.9 Bil
ARGX
argenx SE ADRNyg$24.2 Bil
BNTX
BioNTech SE ADRKrvcy$22.3 Bil
ALNY
Alnylam Pharmaceuticals IncHrgfx$19.9 Bil
BMRN
Biomarin Pharmaceutical IncPnwshd$17.2 Bil
RPRX
Royalty Pharma PLC Class AVmlmbx$13.9 Bil
INCY
Incyte CorpQmvsj$13.6 Bil

Sponsor Center